Table 5 Treatment patterns of those receiving first line monotherapy SSRI treatment
CCAE | MDCD | MDCR | Optum | |||||
|---|---|---|---|---|---|---|---|---|
Received first line SSRI (monotherapy) | 34,453 | 8292 | 1341 | 19,588 | ||||
Patients on first line SSRI monotherapy who went on to receive second treatment class | 19,231 | 55.8% | 4812 | 58.0% | 703 | 52.4% | 10,090 | 51.5% |
Second line is combination therapy | 7814 | 40.6% | 1784 | 37.1% | 265 | 37.7% | 4034 | 40.0% |
Second line is combination therapy which includes an SSRI | 6085 | 31.6% | 1309 | 27.2% | 224 | 31.9% | 3200 | 31.7% |
Second line is combination therapy of SSRI + antipsychotic | 828 | 4.3% | 325 | 6.8% | 31 | 4.4% | 385 | 3.8% |